BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  SeqLL Installs true Single Molecule Sequencing (tSMS) Instrument to Support Oncology Research by Dr. David Ting, MD at the Harvard-MGH Cancer Center

  Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist with a focus on gastrointestinal malignancies.

  November 3, 2017

   · 

  3 min read
• Business

  Nicox Highlights VYZULTA Approval, Latest Corporate and Financial Developments, and Upcoming Pipeline Initiatives

  The company provided an overview yesterday.

  November 3, 2017

   · 

  9 min read
• BioMidwest

  Vertex Announces Presentations of Data at North American Cystic Fibrosis Conference that Demonstrate Important Progress Toward Goal of Helping All People With CF

  Vertex announced presentations of data at the Annual North American Cystic Fibrosis Conference (NACFC), November 2 to 4, 2017, in Indianapolis, from across the company’s portfolio of cystic fibrosis (CF).

  November 3, 2017

   · 

  20 min read
• Genetown

  Fresenius Medical Care Renal Therapies Group Announces Four Abstracts on Velphoro® Accepted for Presentation at the American Society of Nephrology Kidney Week

  The abstracts describe the real world outcomes in serum phosphorus control and a significant reduction in pill burden achieved in hemodialysis patients who switched to Velphoro as part of their routine clinical care.

  November 3, 2017

   · 

  4 min read
• 

  Deals

  CombiMatrix Reminds Shareholders to Vote “FOR” the Merger With Invitae

  Although 96% of votes cast to date are in favor of the merger, a majority of shares outstanding must vote “for” the transaction.

  November 3, 2017

   · 

  9 min read
• Business

  Pacific Biosciences Appoints Kathy Ordonez as Chief Commercial Officer

  Ms. Ordonez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies.

  November 3, 2017

   · 

  3 min read
• Business

  Corcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

  Third quarter revenue of $42.8 million, an increase of 97 percent from third quarter 2016.

  November 3, 2017

   · 

  10 min read
• Business

  Fluidigm Announces Third Quarter Financial Results and Operational Progress

  Total revenue for the third quarter was $24.7 million, an increase of 12% from $22.2 million in the third quarter of 2016 and an increase of 3% from $23.9 million in the second quarter of 2017.

  November 3, 2017

   · 

  18 min read
• Drug Development

  Flexion Therapeutics Highlights Two Clinical Data Presentations at the 2017 American College of Rheumatology Annual Meeting

  Zilretta is a non-opioid medicine that employs Flexion’s proprietary microsphere technology.

  November 3, 2017

   · 

  10 min read
• Business

  IRIDEX Announces 2017 Third Quarter Financial Results

  The company reported record third quarter revenue of $10.9 million, an 11% year-over-year increase.

  November 3, 2017

   · 

  6 min read